Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Eventide Asset Management, LLC reported a 5.90% stake in Collegium Pharmaceutical, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Eventide Asset Management, LLC reported a 5.90% stake in Collegium Pharmaceutical, Inc., 1,876,239 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 5.90%
- Shares
- 1,876,239
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 5.90% | 1,876,239 |
| Finny Kuruvilla, M.D. Ph. D. | 5.90% | 1,876,239 |
| Robin C. John | 5.90% | 1,876,239 |
Source
Related
- Collegium Pharmaceutical, Inc.
- Eventide Asset Management, LLC
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · May 15, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026